Literature DB >> 33636222

The effect of variable troponin C mutation thin filament incorporation on cardiac muscle twitch contractions.

Srboljub M Mijailovich1, Momcilo Prodanovic2, Corrado Poggesi3, Joseph D Powers4, Jennifer Davis5, Michael A Geeves6, Michael Regnier5.   

Abstract

One of the complexities of understanding the pathology of familial forms of cardiac diseases is the level of mutation incorporation in sarcomeres. Computational models of the sarcomere that are spatially explicit offer an approach to study aspects of mutational incorporation into myofilaments that are more challenging to get at experimentally. We studied two well characterized mutations of cardiac TnC, L48Q and I61Q, that decrease or increase the release rate of Ca2+ from cTnC, k-Ca, resulting in HCM and DCM respectively [1]. Expression of these mutations in transgenic mice was used to provide experimental data for incorporation of 30 and 50% (respectively) into sarcomeres. Here we demonstrate that fixed length twitch contractions of trabeculae from mice containing mutant differ from WT; L48Q trabeculae have slower relaxation while I61Q trabeculae have markedly reduced peak tension. Using our multiscale modelling approach [2] we were able to describe the tension transients of WT mouse myocardium. Tension transients for the mutant cTnCs were simulated with changes in k-Ca, measured experimentally for each cTnC mutant in whole troponin complex, a change in the affinity of cTnC for cTnI, and a reduction in the number of detached crossbridges available for binding. A major advantage of the multiscale explicit 3-D model is that it predicts the effects of variable mutation incorporation, and the effects of variations in mutation distribution within thin filaments in sarcomeres. Such effects are currently impossible to explore experimentally. We explored random and clustered distributions of mutant cTnCs in thin filaments, as well as distributions of individual thin filaments with only WT or mutant cTnCs present. The effects of variable amounts of incorporation and non-random distribution of mutant cTnCs are more marked for I61Q than L48Q cTnC. We conclude that this approach can be effective for study on mutations in multiple proteins of the sarcomere.
SUMMARY: A challenge in experimental studies of diseases is accounting for the effect of variable mutation incorporation into myofilaments. Here we use a spatially explicit computational approach, informed by experimental data from transgenic mice expressing one of two mutations in cardiac Troponin C that increase or decrease calcium sensitivity. We demonstrate that the model can accurately describe twitch contractions for the data and go on to explore the effect of variable mutant incorporation and localization on simulated cardiac muscle twitches.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cardiac; Computational model; Simulations; Troponin C mutation; Twitch kinetics; Variable incorporation

Mesh:

Substances:

Year:  2021        PMID: 33636222      PMCID: PMC8240760          DOI: 10.1016/j.yjmcc.2021.02.009

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  71 in total

1.  The measurement and dynamic implications of thin filament lengths in heart muscle.

Authors:  T F Robinson; S Winegrad
Journal:  J Physiol       Date:  1979-01       Impact factor: 5.182

2.  Cooperative [Ca²+]-dependent regulation of the rate of myosin binding to actin: solution data and the tropomyosin chain model.

Authors:  Michael Geeves; Hugh Griffiths; Srboljub Mijailovich; David Smith
Journal:  Biophys J       Date:  2011-06-08       Impact factor: 4.033

3.  X-ray diffraction evidence for the extensibility of actin and myosin filaments during muscle contraction.

Authors:  K Wakabayashi; Y Sugimoto; H Tanaka; Y Ueno; Y Takezawa; Y Amemiya
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

4.  Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.

Authors:  J C Tardiff; T E Hewett; B M Palmer; C Olsson; S M Factor; R L Moore; J Robbins; L A Leinwand
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

5.  Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.

Authors:  Yingcai Wang; Jose Renato Pinto; Raquel Sancho Solis; David Dweck; Jingsheng Liang; Zoraida Diaz-Perez; Ying Ge; Jeffery W Walker; James D Potter
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

6.  A spatially explicit nanomechanical model of the half-sarcomere: myofilament compliance affects Ca(2+)-activation.

Authors:  P Bryant Chase; J Michael Macpherson; Thomas L Daniel
Journal:  Ann Biomed Eng       Date:  2004-11       Impact factor: 3.934

7.  Cooperative regulation of myosin-actin interactions by a continuous flexible chain II: actin-tropomyosin-troponin and regulation by calcium.

Authors:  D A Smith; M A Geeves
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

8.  Length, force, and Ca(2+)-troponin C affinity in cardiac and slow skeletal muscle.

Authors:  Y P Wang; F Fuchs
Journal:  Am J Physiol       Date:  1994-04

9.  A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy.

Authors:  Jennifer Davis; L Craig Davis; Robert N Correll; Catherine A Makarewich; Jennifer A Schwanekamp; Farid Moussavi-Harami; Dan Wang; Allen J York; Haodi Wu; Steven R Houser; Christine E Seidman; Jonathan G Seidman; Michael Regnier; Joseph M Metzger; Joseph C Wu; Jeffery D Molkentin
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

10.  Enhanced Ca2+ binding of cardiac troponin reduces sarcomere length dependence of contractile activation independently of strong crossbridges.

Authors:  F Steven Korte; Erik R Feest; Maria V Razumova; An-Yue Tu; Michael Regnier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-03       Impact factor: 4.733

View more
  2 in total

Review 1.  Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside.

Authors:  Chiara Palandri; Lorenzo Santini; Alessia Argirò; Francesca Margara; Ruben Doste; Alfonso Bueno-Orovio; Iacopo Olivotto; Raffaele Coppini
Journal:  Drugs       Date:  2022-06-13       Impact factor: 11.431

2.  Effect of Myosin Isoforms on Cardiac Muscle Twitch of Mice, Rats and Humans.

Authors:  Momcilo Prodanovic; Michael A Geeves; Corrado Poggesi; Michael Regnier; Srboljub M Mijailovich
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.